Key terms
About SOPH
SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. It operates through the following geographical segments: France, Italy, United States, Spain, Turkey, Austria, Brazil, United Kingdom, Switzerland, Germany, and Other. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest SOPH news
Apr 30
9:49pm ET
SOPHiA GENETICS (SOPH) Gets a Buy from RBC Capital
Apr 23
5:13am ET
Sophia Genetics reports Syndicate Bio as first liquid biopsy customer in Africa
Apr 08
9:46pm ET
RBC Capital Sticks to Its Buy Rating for SOPHiA GENETICS (SOPH)
Apr 04
6:01am ET
Sophia Genetics, Strand Life Sciences announce new strategic partnership
Mar 20
10:02am ET
Sophia Genetics announces first HRD customer in Canada
Mar 06
7:20am ET
Analysts Offer Insights on Healthcare Companies: SOPHiA GENETICS (SOPH), Green Thumb Industries (OtherGTBIF) and Marinus (MRNS)
Mar 06
7:17am ET
Sophia Genetics price target raised to $8 from $7 at BTIG
Mar 06
6:17am ET
Buy Rating Affirmed for SOPHiA GENETICS Amid Growth and Market Expansion Potential
Mar 05
9:35pm ET
TD Cowen Remains a Buy on SOPHiA GENETICS (SOPH)
Mar 05
3:43pm ET
Sophia Genetics SA trading resumes
Mar 05
3:38pm ET
Sophia Genetics SA trading halted, volatility trading pause
Mar 05
6:50am ET
Sophia Genetics sees 2024 revenue $78M-$81M, consensus $82.11M
Mar 05
6:49am ET
Sophia Genetics reports Q4 EPS (37c) vs. (22c) last year
Feb 07
7:10am ET
Sophia Genetics, AstraZeneca Spain to increase ovarian cancer testing in Spain
No recent press releases are available for SOPH
SOPH Financials
Key terms
Ad Feedback
SOPH Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
SOPH Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range